An update on the toxicity of Aβ in Alzheimer’s disease
Jürgen Götz1, Lars M Ittner1, Nicole Schonrock1, Roberto Cappai21Alzheimer’s and Parkinson’s Disease Laboratory, Brain and Mind Research Institute, University of Sydney, NSW, Australia; 2Department of Pathology, The University of Melbourne, Victo...
Guardado en:
Autores principales: | Jürgen Götz, Lars M Ittner, Nicole Schonrock, Roberto Cappai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5f855e5836944cf9e7885f9fdbf9170 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012) -
Update on the use of memantine in Alzheimer’s disease
por: Robert J van Marum
Publicado: (2009) -
Brain amyloid β protein and memory disruption in Alzheimer’s disease
por: Weiming Xia
Publicado: (2010) -
Parkinson’s disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar Ö, et al.
Publicado: (2012) -
Tiagabine: efficacy and safety in partial seizures – current status
por: Jürgen Bauer, et al.
Publicado: (2008)